Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.

Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, Chodosh LA, Belka G, Thompson CB, Kung HF.

J Nucl Med. 2011 Dec;52(12):1947-55. doi: 10.2967/jnumed.111.093815. Epub 2011 Nov 15.

2.

Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.

Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF.

J Nucl Med. 2012 Oct;53(10):1616-24. doi: 10.2967/jnumed.111.101279. Epub 2012 Aug 30.

3.

18F-(2S,4R)4-fluoroglutamine.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Dec 15 [updated 2012 Jan 26].

4.

Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.

Qu W, Oya S, Lieberman BP, Ploessl K, Wang L, Wise DR, Divgi CR, Chodosh LA, Thompson CB, Kung HF.

J Nucl Med. 2012 Jan;53(1):98-105. doi: 10.2967/jnumed.111.093831. Epub 2011 Dec 15. Erratum in: J Nucl Med. 2012 Apr;53(4):646. Chodosh, Lewis P [corrected to Chodosh, Lewis A].

5.

Metabolic Imaging of Glutamine in Cancer.

Zhu L, Ploessl K, Zhou R, Mankoff D, Kung HF.

J Nucl Med. 2017 Apr;58(4):533-537. doi: 10.2967/jnumed.116.182345. Epub 2017 Feb 23. Review.

PMID:
28232608
6.

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

Wu Z, Zha Z, Li G, Lieberman BP, Choi SR, Ploessl K, Kung HF.

Mol Pharm. 2014 Nov 3;11(11):3852-66. doi: 10.1021/mp500236y. Epub 2014 Aug 11.

7.

Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.

Cooper AJ, Krasnikov BF, Pinto JT, Kung HF, Li J, Ploessl K.

Comp Biochem Physiol B Biochem Mol Biol. 2012 Sep;163(1):108-20. doi: 10.1016/j.cbpb.2012.05.010. Epub 2012 May 19.

8.

Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.

Hassanein M, Hight MR, Buck JR, Tantawy MN, Nickels ML, Hoeksema MD, Harris BK, Boyd K, Massion PP, Manning HC.

Mol Imaging Biol. 2016 Feb;18(1):18-23. doi: 10.1007/s11307-015-0862-4.

9.

Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.

Wang L, Zha Z, Qu W, Qiao H, Lieberman BP, Plössl K, Kung HF.

Nucl Med Biol. 2012 Oct;39(7):933-43. doi: 10.1016/j.nucmedbio.2012.03.007. Epub 2012 Apr 26.

10.

Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.

Wuest M, Trayner BJ, Grant TN, Jans HS, Mercer JR, Murray D, West FG, McEwan AJ, Wuest F, Cheeseman CI.

Nucl Med Biol. 2011 May;38(4):461-75. doi: 10.1016/j.nucmedbio.2010.11.004. Epub 2011 Feb 4.

PMID:
21531283
11.

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, Carlin SD, La Rocca G, Lyashchenko S, Ploessl K, Rohle D, Omuro AM, Cross JR, Brennan CW, Weber WA, Holland EC, Mellinghoff IK, Kung HF, Lewis JS, Thompson CB.

Sci Transl Med. 2015 Feb 11;7(274):274ra17. doi: 10.1126/scitranslmed.aaa1009.

12.

Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.

Denholt CL, Binderup T, Stockhausen MT, Poulsen HS, Spang-Thomsen M, Hansen PR, Gillings N, Kjær A.

Nucl Med Biol. 2011 May;38(4):509-15. doi: 10.1016/j.nucmedbio.2010.11.003. Epub 2011 Mar 1.

PMID:
21531288
13.

Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.

Webster JM, Morton CA, Johnson BF, Yang H, Rishel MJ, Lee BD, Miao Q, Pabba C, Yapp DT, Schaffer P.

J Nucl Med. 2014 Apr;55(4):657-64. doi: 10.2967/jnumed.113.126664. Epub 2014 Feb 27.

14.

Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.

Michelhaugh SK, Muzik O, Guastella AR, Klinger NV, Polin LA, Cai H, Xin Y, Mangner TJ, Zhang S, Juhász C, Mittal S.

J Nucl Med. 2017 Feb;58(2):208-213. doi: 10.2967/jnumed.116.179994. Epub 2016 Oct 20.

PMID:
27765857
15.

[18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition.

Zhou R, Pantel AR, Li S, Lieberman BP, Ploessl K, Choi H, Blankemeyer E, Lee H, Kung HF, Mach RH, Mankoff DA.

Cancer Res. 2017 Mar 15;77(6):1476-1484. doi: 10.1158/0008-5472.CAN-16-1945. Epub 2017 Feb 15.

PMID:
28202527
16.

In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.

Furumoto S, Shinbo R, Iwata R, Ishikawa Y, Yanai K, Yoshioka T, Fukuda H.

J Nucl Med. 2013 Aug;54(8):1354-61. doi: 10.2967/jnumed.112.113571. Epub 2013 Jul 10.

17.

Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.

Zhang X, Basuli F, Shi ZD, Xu B, Blackman B, Choyke PL, Swenson RE.

Appl Radiat Isot. 2016 Jun;112:110-4. doi: 10.1016/j.apradiso.2016.02.016. Epub 2016 Mar 17.

PMID:
27019029
18.

Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.

Wang H, Zhang J, Tian J, Qu B, Li T, Chen Y, Liu J, Wang S.

J Nucl Med. 2009 Nov;50(11):1857-64. doi: 10.2967/jnumed.109.064238. Epub 2009 Oct 16. Erratum in: J Nucl Med. 2010 Jan;51(1):167.

19.

Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.

McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N.

Nucl Med Biol. 2011 Oct;38(7):953-9. doi: 10.1016/j.nucmedbio.2011.02.017. Epub 2011 May 6.

PMID:
21982567
20.

In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.

Warnock G, Turtoi A, Blomme A, Bretin F, Bahri MA, Lemaire C, Libert LC, Seret AE, Luxen A, Castronovo V, Plenevaux AR.

J Nucl Med. 2013 Oct;54(10):1782-8. doi: 10.2967/jnumed.112.117150. Epub 2013 Aug 22.

Supplemental Content

Support Center